-
Something wrong with this record ?
Anticancer activity of natural cytokinins: a structure-activity relationship study
J. Voller, M. Zatloukal, R. Lenobel, K. Dolezal, T. Béres, V. Krystof, L. Spíchal, P. Niemann, P. Dzubák, M. Hajdúch, M. Strnad
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Adenosine analogs & derivatives chemistry pharmacology MeSH
- Cytokinins analysis chemistry metabolism MeSH
- Genes, p53 drug effects genetics MeSH
- Inhibitory Concentration 50 MeSH
- Isopentenyladenosine analogs & derivatives chemistry pharmacology MeSH
- Kinetin chemistry pharmacology MeSH
- Humans MeSH
- Molecular Structure MeSH
- National Cancer Institute (U.S.) MeSH
- Antineoplastic Agents chemistry pharmacology MeSH
- Plant Growth Regulators pharmacology MeSH
- Drug Screening Assays, Antitumor MeSH
- Stereoisomerism MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- United States MeSH
Cytokinin ribosides (N(6)-substituted adenosine derivatives) have been shown to have anticancer activity both in vitro and in vivo. This study presents the first systematic analysis of the relationship between the chemical structure of cytokinins and their cytotoxic effects against a panel of human cancer cell lines with diverse histopathological origins. The results confirm the cytotoxic activity of N(6)-isopentenyladenosine, kinetin riboside, and N(6)-benzyladenosine and show that the spectrum of cell lines that are sensitive to these compounds and their tissues of origin are wider than previously reported. The first evidence that the hydroxylated aromatic cytokinins (ortho-, meta-, para-topolin riboside) and the isoprenoid cytokinin cis-zeatin riboside have cytotoxic activities is presented. Most cell lines in the panel showed greatest sensitivity to ortho-topolin riboside (IC(50)=0.5-11.6 microM). Cytokinin nucleotides, some synthesized for the first time in this study, were usually active in a similar concentration range to the corresponding ribosides. However, cytokinin free bases, 2-methylthio derivatives and both O- and N-glucosides showed little or no toxicity. Overall the study shows that structural requirements for cytotoxic activity of cytokinins against human cancer cell lines differ from the requirements for their activity in plant bioassays. The potent anticancer activity of ortho-topolin riboside (GI(50)=0.07-84.60 microM, 1st quartile=0.33 microM, median=0.65 microM, 3rd quartile=1.94 microM) was confirmed using NCI(60), a standard panel of 59 cell lines, originating from nine different tissues. Further, the activity pattern of oTR was distinctly different from those of standard anticancer drugs, suggesting that it has a unique mechanism of activity. In comparison with standard drugs, oTR showed exceptional cytotoxic activity against NCI(60) cell lines with a mutated p53 tumour suppressor gene. oTR also exhibited significant anticancer activity against several tumour models in in vivo hollow fibre assays.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026336
- 003
- CZ-PrNML
- 005
- 20130520133041.0
- 007
- ta
- 008
- 120817e20100601xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.phytochem.2010.04.018 $2 doi
- 035 __
- $a (PubMed)20553699
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Voller, Jiří. $7 _AN043406 $u Laboratory of Growth Regulators, Palacký University and Institute of Experimental Botany ASCR, Slechtitelů 11, 783 71 Olomouc, Czech Republic.
- 245 10
- $a Anticancer activity of natural cytokinins: a structure-activity relationship study / $c J. Voller, M. Zatloukal, R. Lenobel, K. Dolezal, T. Béres, V. Krystof, L. Spíchal, P. Niemann, P. Dzubák, M. Hajdúch, M. Strnad
- 520 9_
- $a Cytokinin ribosides (N(6)-substituted adenosine derivatives) have been shown to have anticancer activity both in vitro and in vivo. This study presents the first systematic analysis of the relationship between the chemical structure of cytokinins and their cytotoxic effects against a panel of human cancer cell lines with diverse histopathological origins. The results confirm the cytotoxic activity of N(6)-isopentenyladenosine, kinetin riboside, and N(6)-benzyladenosine and show that the spectrum of cell lines that are sensitive to these compounds and their tissues of origin are wider than previously reported. The first evidence that the hydroxylated aromatic cytokinins (ortho-, meta-, para-topolin riboside) and the isoprenoid cytokinin cis-zeatin riboside have cytotoxic activities is presented. Most cell lines in the panel showed greatest sensitivity to ortho-topolin riboside (IC(50)=0.5-11.6 microM). Cytokinin nucleotides, some synthesized for the first time in this study, were usually active in a similar concentration range to the corresponding ribosides. However, cytokinin free bases, 2-methylthio derivatives and both O- and N-glucosides showed little or no toxicity. Overall the study shows that structural requirements for cytotoxic activity of cytokinins against human cancer cell lines differ from the requirements for their activity in plant bioassays. The potent anticancer activity of ortho-topolin riboside (GI(50)=0.07-84.60 microM, 1st quartile=0.33 microM, median=0.65 microM, 3rd quartile=1.94 microM) was confirmed using NCI(60), a standard panel of 59 cell lines, originating from nine different tissues. Further, the activity pattern of oTR was distinctly different from those of standard anticancer drugs, suggesting that it has a unique mechanism of activity. In comparison with standard drugs, oTR showed exceptional cytotoxic activity against NCI(60) cell lines with a mutated p53 tumour suppressor gene. oTR also exhibited significant anticancer activity against several tumour models in in vivo hollow fibre assays.
- 650 _2
- $a adenosin $x analogy a deriváty $x chemie $x farmakologie $7 D000241
- 650 _2
- $a protinádorové látky $x chemie $x farmakologie $7 D000970
- 650 _2
- $a cytokininy $x analýza $x chemie $x metabolismus $7 D003583
- 650 _2
- $a screeningové testy protinádorových léčiv $7 D004354
- 650 _2
- $a geny p53 $x účinky léků $x genetika $7 D016158
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibiční koncentrace 50 $7 D020128
- 650 _2
- $a isopentenyladenosin $x analogy a deriváty $x chemie $x farmakologie $7 D007541
- 650 _2
- $a kinetin $x chemie $x farmakologie $7 D007701
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a National Cancer Institute (U.S.) $7 D054547
- 650 _2
- $a regulátory růstu rostlin $x farmakologie $7 D010937
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 651 _2
- $a Spojené státy americké $7 D014481
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zatloukal, Marek $7 xx0113001
- 700 1_
- $a Lenobel, René
- 700 1_
- $a Dolezal, Karel
- 700 1_
- $a Béres, Tibor
- 700 1_
- $a Krystof, Vladimír
- 700 1_
- $a Spíchal, Lukáš $7 xx0123817
- 700 1_
- $a Niemann, Percy
- 700 1_
- $a Dzubák, Petr
- 700 1_
- $a Džubák, Petr $7 xx0080445
- 700 1_
- $a Strnad, Miroslav, $d 1958- $7 jn20010309068
- 773 0_
- $w MED00003829 $t Phytochemistry $x 1873-3700 $g Roč. 71, č. 11-12 (20100601), s. 1350-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20553699 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20130520133400 $b ABA008
- 999 __
- $a ok $b bmc $g 948378 $s 783682
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 71 $c 11-12 $d 1350-9 $e 20100601 $i 1873-3700 $m Phytochemistry $n Phytochemistry $x MED00003829
- LZP __
- $a Pubmed-20120817/10/04